메뉴 건너뛰기




Volumn 33, Issue 4, 2006, Pages 194-197

Clinical significance of serum cellular fibronectin concentrations in gastric cancer and precancerous diseases of stomach

Author keywords

Cellular fibronectin; ELISA; Gastric neoplasm

Indexed keywords

FIBRONECTIN;

EID: 33645062455     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (10)
  • 1
    • 0028875886 scopus 로고
    • Alternative splicing of fibronectin many different proteins but few different functions
    • French-Constant C. Alternative splicing of fibronectin many different proteins but few different functions [J]. Exp Cell Res, 1995, 221(2):261-271
    • (1995) Exp Cell Res , vol.221 , Issue.2 , pp. 261-271
    • French-Constant, C.1
  • 2
    • 0028962199 scopus 로고
    • Cellular fibronectin in serum and plasma: A potential new tumour marker
    • Ylatupa S, Haglund C, Mertaniemi P, et al. Cellular fibronectin in serum and plasma: a potential new tumour marker [J]? Br J Cancer, 1995, 71(3):578-582
    • (1995) Br J Cancer , vol.71 , Issue.3 , pp. 578-582
    • Ylatupa, S.1    Haglund, C.2    Mertaniemi, P.3
  • 3
    • 0027179645 scopus 로고
    • Competitive enzyme immunoassay for quantitation of cellular form of fibronectin (EDAcFN) in blood samples
    • Ylatupa S, Partanen P, Haglund C, et al. Competitive enzyme immunoassay for quantitation of cellular form of fibronectin (EDAcFN) in blood samples [J]. J Immunol Methods, 1993, 163 (1):41-47
    • (1993) J Immunol Methods , vol.163 , Issue.1 , pp. 41-47
    • Ylatupa, S.1    Partanen, P.2    Haglund, C.3
  • 4
    • 0028919178 scopus 로고
    • An improved method for quantification of extra domain a -containing cellular fibronectin (EDAcFN) in different body fluids
    • Ylatupa S, Mertaniemi P, Haglund C, et al. An improved method for quantification of extra domain A -containing cellular fibronectin (EDAcFN) in different body fluids [J]. Clinica Chimica Acta, 1995, 234(1):79-90
    • (1995) Clinica Chimica Acta , vol.234 , Issue.1 , pp. 79-90
    • Ylatupa, S.1    Mertaniemi, P.2    Haglund, C.3
  • 5
    • 0030851122 scopus 로고    scopus 로고
    • Cellular fibronectin concentration in plasma of patients with malignant and benign diseases: A comparison with CA19-9 and CEA
    • Haglund C, Ylatupa S, Mertaniemi P, et al. Cellular fibronectin concentration in plasma of patients with malignant and benign diseases: a comparison with CA19-9 and CEA [J]. Br J Cancer, 1997, 76(6):777-783
    • (1997) Br J Cancer , vol.76 , Issue.6 , pp. 777-783
    • Haglund, C.1    Ylatupa, S.2    Mertaniemi, P.3
  • 6
    • 0023936167 scopus 로고
    • The extracellular matrix and neoplasia
    • Martinez-Hernandez A. The extracellular matrix and neoplasia[J]. Lab Invest, 1988, 58(6):609-611
    • (1988) Lab Invest , vol.58 , Issue.6 , pp. 609-611
    • Martinez-Hernandez, A.1
  • 7
    • 0033822959 scopus 로고    scopus 로고
    • Evaluation of two new urinary tumor markers: Bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder
    • Marta S, Manel U, Jose M, et al. Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder [J]. Clin Cancer Res, 2000, 6 (9):3585-3594
    • (2000) Clin Cancer Res , vol.6 , Issue.9 , pp. 3585-3594
    • Marta, S.1    Manel, U.2    Jose, M.3
  • 8
    • 33645054515 scopus 로고    scopus 로고
    • Chinese source
  • 9
    • 33645045803 scopus 로고    scopus 로고
    • Chinese source
  • 10
    • 0028290240 scopus 로고
    • Possible role of Helicobacter pylori in early gastric cancer development
    • Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori in early gastric cancer development [J]. Cancer, 1994, 73 (11):2691-2694
    • (1994) Cancer , vol.73 , Issue.11 , pp. 2691-2694
    • Asaka, M.1    Kimura, T.2    Kato, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.